BIIB — BIOGEN INC

Health Care

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BIIB?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
75
Institutional Conviction
Mixed · 3 buying vs 1 selling last quarter
49
Macro Tailwind
Macro conditions are a headwind for Health Care
36
Congressional Activity
1 congressional purchase, 1 sale disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their BIIB position last quarter, 3 bought and 1 sold (75% buy-side). Macro conditions are a headwind for Health Care (Macro Tailwind 36/100 in a Expansion regime). 1 congressional purchase, 1 sale disclosed in the last 6 months.

Supporting evidence
  • +3 tracked investors added or increased positions last quarter (Paul Tudor Jones, Izzy Englander, Ken Griffin)
  • +4 tracked investors reported holding BIIB at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
  • −Current Expansion regime has historically been a headwind for Health Care (Macro Tailwind 36/100)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.

About BIOGEN INC (BIIB)

BIOGEN INC (BIIB) appears in the most recent 13F filings of 4 tracked institutional investors. BIOGEN INC is classified in the Health Care sector. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $683M. Across recent filings, tracked investors recorded 7 new positions, 15 increased, 16 reduced, and 3 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BIIB

54
/100
Mixed Activity
Added / Increased22
Reduced16
Exited3
BearishBullish
Crowded Trade Score™

How many top investors track BIIB

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

BIIB Ownership Composition

How BIOGEN INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
99% of tracked value
Institutions
4
tracked investors
Total Reported
$523.8M
combined 13F value
Types2
  • Multi-Strategy / Quant98.8%
  • Macro1.2%
Multi-Strategy / Quant(3)
98.8%
Macro(1)
1.2%

Tracked investors currently reporting BIIB

1 tracked investor has since exited this position — listed separately below.

  • Steve CohenSep 30, 2026
    Point72 Asset Management
    Shares
    3.9K
    Value
    $880.9K
    % Portfolio
    0.00%
  • Ken GriffinSep 30, 2026
    Citadel Advisors
    Shares
    2M
    Value
    $442M
    % Portfolio
    0.05%
  • Izzy EnglanderSep 30, 2026
    Millennium Management
    Shares
    329.9K
    Value
    $74.5M
    % Portfolio
    0.02%
  • Paul Tudor JonesSep 30, 2026
    Tudor Investment Corp
    Shares
    28.3K
    Value
    $6.4M
    % Portfolio
    0.01%

Previously held BIIB

These investors reported BIIB in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Ray DalioBridgewater Associates40K$5.6KSep 30, 2025

Recent activity

Frequently asked questions

How many institutional investors hold BIIB?
4 tracked institutional investors disclosed a position in BIIB (BIOGEN INC) in their most recent 13F filing.
Who is the largest institutional holder of BIIB?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in BIIB, valued at $683M.
Did institutional ownership of BIIB increase or decrease?
Across recent 13F filings, tracked investors recorded 7 new positions, 15 increased, 16 reduced, and 3 fully exited BIIB.
What sector is BIIB in?
BIOGEN INC is classified in the Health Care GICS sector.
Where does this BIIB ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.